Gilead Sciences (GILD) Set to Acquire Arcellx [Yahoo! Finance]
Arcellx, Inc. (ACLX)
Company Research
Source: Yahoo! Finance
17 the attainment of all required regulatory approvals for its previously announced acquisition of Arcellx. The company also stated that it has extended the expiration of the tender offer to purchase all outstanding shares of common stock of Arcellx. Citi Raises Gilead (GILD) Price Target Ahead of Q1 Biopharma Preview In a separate development, Gilead Sciences, Inc. (NASDAQ:GILD) received a rating update from Truist on April 8, with the firm lifting the price target on the stock to $155 from $152 while reaffirming a Buy rating on the shares. The rating update came as part of a broader research note previewing fiscal Q1 earnings in Biotech, with the firm stating that reactivity to regulatory and policy shifts across the sector is continuing to ease. Truist also noted a recent pickup in deal activity, which it believes holds the potential to build momentum through the remainder of the year into midterms. The firm further told investors in a research note that for Gilead Sciences,
Show less
Read more
Impact Snapshot
Event Time:
ACLX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ACLX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ACLX alerts
High impacting Arcellx, Inc. news events
Weekly update
A roundup of the hottest topics
ACLX
News
- Arcellx (ACLX) had its "neutral" rating reaffirmed by Cantor Fitzgerald.MarketBeat
- Gilead Sciences Completes Acquisition of Arcellx Ahead of Potential Commercial Launch of Anito-cel [Yahoo! Finance]Yahoo! Finance
- Arcellx (ACLX) was upgraded by Truist Financial Corporation to "strong-buy".MarketBeat
- Gilead Receives All Required Regulatory Approvals for the Acquisition of Arcellx and Extends Tender Offer [Yahoo! Finance]Yahoo! Finance
- Assessing Arcellx (ACLX) Valuation After Strong Multi-Year Share Price Gains [Yahoo! Finance]Yahoo! Finance
ACLX
Earnings
- 2/26/26 - Miss
ACLX
Sec Filings
- 4/28/26 - Form 4
- 4/28/26 - Form 4
- 4/28/26 - Form 4
- ACLX's page on the SEC website